Cerulean Pharma Closes Series D

Private Equity Hub  • Dec 15, 2011

Cerulean Pharma, a developer of nanopharmaceuticals, has closed a $15 million Series D financing with participation from new investor, CVF, an affiliate of Henry Crown and Company of Chicago, Illinois, as well as full participation from all other existing investors,… Full Story »

Post Your Comment

separate usernames and emails with a comma



Authenticating User
Loading Global Loud3r Profile